Answers are grounded in this paper and cite their sources.
Peri-implant soft tissue deficiencies may affect the esthetic appearance of implant-supported restorations.Autogenous soft tissue grafting remains established, although donor-site morbidity has encouraged interest in less invasive approaches.This systematic review evaluated the clinical effectiveness of biologically active agents and biomaterials for managing peri-implant soft tissue deficiencies and assessed their impact on clinical, esthetic, and patient-reported outcomes.We searched multiple electronic databases.Eligible studies evaluated biologically active agents or biomaterials for peri-implant soft tissue deficiencies.Two reviewers independently screened studies, extracted data, and assessed risk of bias.Due to substantial heterogeneity in interventions, comparators, outcomes, and follow-up periods, a narrative synthesis was performed on the five eligible studies.Five studies met the eligibility criteria.The findings indicated that free gingival grafts (FGG) remain the most predictable intervention for increasing keratinized mucosa width (KMW).However, injectable platelet-rich fibrin (i-PRF) and hyaluronic acid (HA), especially when combined with microneedling, significantly improved peri-implant mucosal thickness (PIMT) and modified the phenotype.Furthermore, combining FGG with xenogeneic collagen matrices (XCM) provided clinical gains comparable to conventional FGG while significantly reducing postoperative morbidity and enhancing esthetic outcomes.Biologically active agents and biomaterials may improve peri-implant soft tissue outcomes.However, evidence remains limited and heterogeneous, and these approaches cannot currently replace autogenous soft tissue grafting.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: